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Tourniquets are widely used in orthopedic operating 
theatres. The principle cause for using a tourniquet is to 
provide better operative conditions by creating a blood-
less surgical field.[1,2] In spite of its advantages, tourni-
quet use is not absolutely safe, with possible systemic 
and local harmful effects.[2] 
Physicians are responsible for safe tourniquet use,[2] 
as well as any consequences that arise from their use.[3,4] 
With adequate education, the adverse effects are easily 
preventable. However, there is only 1 formal examina-
tion to test knowledge and describe general guidelines 
on tourniquet use for orthopedic surgeons in Turkey.[5]
Objective: The aim of the present pilot study was to evaluate patterns in the current practice of tour-
niquet use in Turkey. The results of this study can provide detailed information regarding tourniquet 
use and evaluate the need for guidelines on tourniquet use in Turkey.
Methods: The questionnaire was sent to orthopedic residents and surgeons by either giving printed 
questionnaires directly or by establishing preliminary communication with surgeons and then send-
ing questionnaires by e-mail. Participating staff consisted of 3 groups: Group 1: orthopedic surgeons; 
Group 2: orthopedic residents; and Group 3: orthopedic academic staff. Statistical differences in tour-
niquet use were analyzed among the groups.
Results: Use of mechanical tourniquet was significantly higher in Group 1. Plain cuffs were used in or-
thopedic surgical practice more frequently. Assistant and orthopedic theatre personnel were commonly 
reported by participants as the tourniquet applicant. Periodic educational practice was not routine. 
The number of reported complications was higher in Group 3. Cuff padding was generally routine 
practice. Scientifically valid options at lowest inflation pressure were not observed among the results 
at the expected rates.
Conclusion: The results of this pilot study indicate that there is wide variation in some aspects of 
tourniquet practice in Turkey. The differences are not acceptable because of the potential for signifi-
cant complications with some practices. There is a need to provide and ensure adequate education to 
provide the best patient care. Furthermore, protocols should be developed for acceptable standards of 
tourniquet use.
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ORIGINAL ARTICLE
The aim of the present pilot study was to evaluate 
patterns in the current practice of tourniquet use in 
Turkey. The results of this study can provide detailed in-
formation about tourniquet use among orthopedic sur-
geons, orthopedic residents, and orthopedic academic 
staff, and define the extent of the need for guidelines on 
tourniquet use in Turkey. 
Materials and methods
This study was approved by Baskent University Institu-
tional Review Board (Project no:KA 13/64) and sup-
ported by Baskent University Research Fund. The data 
for this cross-sectional descriptive study was collected 
from 98 medical personnel. 
A draft of the questionnaire containing 18 questions 
was approved by all authors. The first 12 questions ad-
dress the surgeon, hospital, and technique of pneumatic 
tourniquet application. The remaining 6 questions ad-
dress the surgeon’s knowledge of pneumatic tourniquet 
use. The first section (initial 12 questions) recorded the 
title of the surgeon, the institution where the surgeon 
works, type of pneumatic tourniquet, type of cuff, iden-
tity of person who is applying the tourniquet, regular ed-
ucation about tourniquet use in that clinical unit, experi-
ence of complications in that clinical unit, recording of 
application details (tourniquet type and time, cuff type, 
pressure level), padding beneath the tourniquet, cuff lo-
calization on extremity, determining cuff pressure, and 
method of exsanguination. The second section (remain-
ing 6 question) questioned timing of antibiotic admin-
istration, secure tourniquet time for adult and pediatric 
patients, cause of intraoperative bleeding, tourniquet 
strategy in longer operations, and contraindications of 
tourniquet use (Table 1).
The questionnaire was sent to orthopedic residents 
and orthopedic surgeons working in training and re-
search hospitals, university hospitals, state hospitals, and 
private hospitals by either giving printed questionnaires 
directly or, after preliminary communication with sur-
geons was established, sending questionnaires by e-mail. 
The hospitals were chosen randomly. All orthopedic sur-
Table 1. Survey questions.
1. What is your academic title? (orthopedic surgeon, orthopedic resident, orthopedic academic staff [professor, associated professor,
 assistant professor])
2. Where do you perform surgery? (state hospital, university hospital, training and research hospital, private hospital, other)
3. What type of tourniquet do you use? (electronic, mechanical)
4. What type of tourniquet cuff do you use? (plain, conical, plain or conical according to extremity width)
5. Who applies tourniquet cuff to your patients? (orthopedic surgeon, orthopedic resident, nurse, orthopedic theatre personnel, other)
6  Is there periodic educational practice about tourniquet use in your hospital? (no; yes, biennially; yes, once a year; yes, biannually; other)
7. Have you experienced any tourniquet-related complications? (no; yes, in a patient; yes, in more than one patient; other)
8. Do you record tourniquet type, cuff type, inflation pressure, and tourniquet time during orthopedic theatre routinely? (yes, no)
9. Do you prefer using underlying skin protection material below the cuff? (yes, no)
10. Where do you apply tourniquet cuff on the extremity of a patient? (most proximally, most distally, region of most muscle mass, disregard  
 the region)
11. For lower and upper extremities, what pressure setting do you most commonly use for your patients? ( ___ mmHg for upper extremity  
 ___ mmHg for lower extremity, systolic blood pressure plus 100 mmHg, limb occlusion pressure or arterial occlusion pressure
 determination method, arterial occlusion pressure estimation method, other)
12. How do you exsanguinate the limb prior to tourniquet inflation? (do not exsanguinate, elevation only, Esmarch bandage, both elevation  
 and Esmarch bandage, other)
13. How many minutes before tourniquet inflation do you give antibiotics? (15 min, 20 min, 30 min, 45 min, other)
14. What do you prefer as maximum safe tourniquet inflation time for adult patients? (60 min for upper extremity, 90 min for lower
 extremity; 90 min for upper extremity, 120 min for lower extremity; 60 min for upper extremity, 120 min for lower extremity; 120 min for  
 upper extremity, 120 min for lower extremity; other)
15. What do you prefer as maximum safe tourniquet inflation time for pediatric patients? (120 min, 90 min, 75 min, 60 min, other)
16. If there is bleeding despite using tourniquet during operation, what is the most likely cause? (unsatisfactory initial cuff inflation pressure,  
 increased blood pressure during surgery, tourniquet cuff pressure decreased intraoperatively, all, none)
17. What is your practice if there is a need to exceed safe tourniquet inflation time during surgery? (proceed with the surgery without
 tourniquet; deflate tourniquet, reuse after 5 min break; deflate tourniquet, reuse after 15 min break; deflate tourniquet, reuse after
 30 min break; other)
18. Which is/are contraindication(s) of tourniquet application during extremity surgery? (peripheral vascular disease, infection, malignancy,  
 sickle cell anemia history, all of the above)
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geons and residents, as well as the majority of academic 
staff, were selected from the Aegean Region in Turkey. 
Additionally, questionnaires were sent to randomly cho-
sen orthopedic academic staff outside the Aegean Re-
gion by e-mail.
Participating medical staff consisted of 3 groups: 
Group 1: orthopedic surgeons; Group 2: orthopedic 
residents; and Group 3: orthopedic academic staff (pro-
fessor, associated professor, and assistant professor). 
Statistical differences in tourniquet use were analyzed 
among the groups. Completed questionnaires were re-
corded, and results were exported to SPSS software 
(version 16.0, SPSS Inc., Chicago, IL, USA) for analy-
sis. Descriptive statistics, one-way analysis of variance 
and chi-squared test analysis were used. P values <0.05 
were considered significant.
Results
The study included 98 participants who are actively 
working in orthopedic units. The majority of partici-
pants worked in a university hospital (n=48, 49%). De-
tailed survey results are shown in Tables 2 and 3.
The number of participants who used mechani-
cal tourniquet was significantly higher in Group 
1 (F=13.861, p=0.000; Pearson’s chi-squared 
test=22.138, SD=2, p=0.000). Plain cuffs were used 
in orthopedic surgical practice more frequently (n=72, 
Table 2. Survey results, personal information of the physicians.
    n %
Q1. What is your academic title?
 Orthopedic surgeon 42 42.9
 Orthopedic resident 36 36.7
 Orthopedic academic staff 20 20.4
  Professor 13 13.3
  Associated professor 5 5.1
  Assistant professor 2 2
Q2. Where do you perform surgery?
 State hospital 23 23.5
 University hospital 48 49
 Training and research hospital 5 5.1
 Private hospital 22 22.4
Table 3. Survey results, current practice (G1: Group 1; G2: Group 2; G3: Group 3).
   n %
Q3. What type of tourniquet do you use?  
 Electronic 81 (G1: 26; G2: 35; G3: 20) 82.7
 Mechanical 17 (G1: 16; G2: 1; G3: 0) 17.3
Q4. What type of tourniquet cuff do you use?  
 Plain 72 (G1: 32; G2: 28; G3: 12) 73.5
 Conical 5 (G1: 4; G2: 1; G3: 0) 5.1
 Plain or conical according to extremity width 21 (G1: 6; G2: 7; G3: 8) 21.4
Q5. Who applies tourniquet cuff to your patients?   
 Orthopedic surgeon 20 (G1: 16; G2: 2; G3: 2) 20.6
 Orthopedic resident 43 (G1: 7; G2: 30; G3: 6) 44.3
 Nurse 0 0
 Orthopedic theatre personnel 33 (G1: 19; G2: 3; G3: 11) 34.0
 Other (herself/himself) 1 (G3) 1.0
 (One participant did not answer the question)
Q6: Is there periodic educational practice about tourniquet use in your hospital?
 No 67 (G1: 29; G2: 26; G3: 12) 69.1
 Yes, biennially 5 (G1: 1; G2: 3; G3: 1) 5.2
 Yes, once a year 16 (G1: 7; G2: 7; G3: 2) 16.5
 Yes, biannually 5 (G1: 2; G2: 0; G3: 3) 5.2
 Other 4 (G1: 2; G2: 0; G3: 2) 4.1
 (One participant did not answer the question)
Q7. Have you experienced any tourniquet-related complications?
 No 72 (G1: 37; G2: 27; G3: 8) 74.2
 Yes, in one patient 8 (G1: 2; G2: 4; G3: 2) 8.2
 Yes, in more than one patient 16 (G1: 2; G2: 5; G3: 9) 16.5
 Other 1 (G3) 1.0
 (One participant did not answer the question)
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Table 3. Survey results, current practice (G1: Group 1; G2: Group 2; G3: Group 3). (cont.)
   n %
Q8. Do you record tourniquet type, cuff type, inflation pressure, and tourniquet time
routinely in the orthopedic theatre?
 Yes 77 (G1: 30; G2: 30; G3: 17) 78.6
 No 21 (G1: 12; G2: 6; G3: 3) 21.4
Q9. Do you prefer using an underlying skin protection material below the cuff?
 Yes 93 (G1: 41; G2: 34; G3: 18) 94.9
 No 5 (G1: 1; G2: 2; G3: 2) 5.1
Q10. Where do you apply tourniquet cuff on the extremity of a patient?
 Most proximally 79 (G1: 34; G2: 33; G3: 12) 80.6
 Most distally 1 (G1) 1.0
 Region of most muscle mass  16 (G1: 7; G2: 3; G3: 6) 16.3
 Disregard the region 2 (G3) 2.0
Q11. In lower and upper extremities, what pressure settings do you most commonly
use for your patients?
 ___ mmHg for upper extremity, ___ mmHg for lower extremity (fixed inflation pressures) 38 (G1: 18; G2: 13; G3: 7) 38.8
 Systolic blood pressure plus 100 mmHg 51 (G1: 20; G2: 20; G3: 11) 52.0
 Limb occlusion pressure or arterial occlusion pressure determination method 1 (G1) 1.0
 Arterial occlusion pressure estimation method 2 (G1: 1; G2: 1) 2.0
 Other 6 (G1: 2; G2: 2; G3: 2) 6.1
Q12. How do you exsanguinate the limb prior to tourniquet inflation?
 Do not exsanguinate 9 (G1: 2; G2: 6; G3: 2) 9.2
 Elevation only 23 (G1: 11; G2: 8; G3: 4) 23.5
 Esmarch bandage 45 (G1: 23; G2: 13; G3: 9) 45.9
 Both elevation and Esmarch bandage 21 (G1: 7; G2: 9; G3: 5) 21.4
 Other 0 0
Q13. How many minutes before tourniquet inflation do you give antibiotics? 
 15 min 19 (G1: 8; G2: 4; G3: 7) 19.4
 20 min 13 (G1: 5; G2: 7; G3: 1) 13.3
 30 min 55 (G1: 22; G2: 22; G3: 11) 56.1
 45 min 5 (G1: 3; G2: 2; G3: 0) 5.1
 Other 6 (G1: 4; G2: 1; G3: 1) 6.1
Q14. What do you prefer as maximum safe tourniquet inflation time for adult patients?
 60 min for upper extremity, 90 min for lower extremity 22 (G1: 12; G2: 5; G3: 5) 22.4
 90 min for upper extremity, 120 min for lower extremity 44 (G1: 12; G2: 23; G3: 9) 44.9
 60 min for upper extremity, 120 min for lower extremity 8 (G1: 7; G2: 1; G3: 0) 8.2
 120 min for upper extremity, 120 min for lower extremity 21 (G1: 10; G2: 7; G3: 4) 21.4
 Other 3 (G1: 1; G2: 0; G3: 2) 3.1
Q15. What do you prefer as maximum safe tourniquet inflation time for pediatric patients?
 120 min 14 (G1: 5; G2: 7; G3: 2) 14.4
 90 min 42 (G1: 13; G2: 17; G3: 12) 43.3
 75 min 7 (G1: 2; G2: 3; G3: 2) 7.2
 60 min 31 (G1: 20; G2: 9; G3: 2) 32.0
 Other 3 (G1: 2; G2: 0; G3: 1) 3.1
 (One participant did not answer the question)
Q16. If there is bleeding despite using a tourniquet during operation, what is the
 most likely cause? 
 Unsatisfactory initial cuff inflation pressure 15 (G1: 4; G2: 10; G3: 1) 15.3
 Increased blood pressure during surgery 6 (G1: 2; G2: 4; G3: 0) 6.1
 Decreased intraoperative tourniquet cuff pressure  24 (G1: 11; G2: 7; G3: 6) 24.5
 All 51 (G1: 25; G2: 15; G3: 11) 52.0
 None 2 (G3) 2.0
73.5%) than conical cuffs (n=5, 5.1%). Assistant (n=43, 
44.3%) and orthopedic theatre personnel (n=33, 34%) 
were commonly reported as the tourniquet applicant. 
Periodic education was not routine practice in most of 
the clinics, as 67 participants (69.1%) responded “no.” 
Most participants (n=72, 74.2%) had encoun-
tered no complications. The number of reported 
complications was statistically significantly higher in 
Group 3 (F=13.336, p=0.000; Pearson’s chi-squared 
test=19.004, SD=1, p=0.000). Technical details about 
tourniquet use appear to be recorded regularly in the 
operating theatre (n=77, 78.6%). Underlying skin pro-
tection material underneath the cuff was reported by 
93 participants (94.9%). According to determination 
of cuff localization, half of the participants in Group 
3 reported that they applied the cuff on the region of 
the extremity with the greatest muscle mass (F=5.530, 
p=0.005). Fixed inflation pressures (n=38, 38.8%) and 
systolic blood pressure plus 100 mmHg (n=51, 52%) 
were commonly reported options for setting the cuff 
pressure. Esmarch bandage exsanguination procedure 
was the most commonly reported procedure by partici-
pants (n=45, 45.9%). 
A 20–30 minute interval between antibiotic ad-
ministration and tourniquet inflation was the most fre-
quently chosen interval by survey participants (n=68, 
69.4%). Ninety minutes for upper extremity and 120 
minutes for lower extremity were reported as maximum 
safe tourniquet inflation time for adult patients by 44 
participants (44.9%). Only 38 participants (39.2%) re-
ported equal or below 75 minutes in pediatric patients 
for maximum safe tourniquet inflation time. There was a 
statistically significant difference among the groups with 
respect to maximum safe tourniquet inflation time for 
pediatric patients (Pearson’s chi-squared test= 5.776, 
SD=1, p=0.16).
Fifty-one participants (52%) stated that if there is 
bleeding despite intraoperative tourniquet use, there 
may be unsatisfactory initial cuff inflation pressure or 
increased blood pressure during surgery, or decreased 
tourniquet cuff pressure intraoperatively. Distribution 
of orthopedic residents’ answers was statistically signifi-
cantly different to the other groups (F=5.395, p=0.006). 
Forty-eight participants (49%) reported that they pro-
ceed with surgery without a tourniquet if there is a need 
to exceed safe tourniquet inflation time during surgery. 
Peripheral vascular disease, infection, malignancy, or 
sickle cell anemia history were reported as causes of 
complications by 21 participants (21.7%). Seventy-six 
participants (78.4%) chose all options for this question. 
Discussion
An inflatable cuff, a compressed gas source, and a mi-
croprocessor-controlled pressure regulator that main-
tains cuff pressure are the main components of digital 
tourniquets, which have a monitor display showing cuff 
pressure and inflation time.[6] Additionally, there is an 
audiovisual alarm that is triggered by cuff leaks, exces-
sively high or low cuff pressures, or prolonged tourni-
quet time.[6] Mechanical tourniquets have a pump to 
provide compressed gas, a mechanical monitor to display 
cuff pressure, and a connection attachment to the cuff. 
No orthopedic academic staff used mechanical tourni-
quet; orthopedic surgeons were the most common users 
of mechanical tourniquet in the survey. 
The majority of participants (n=72, 73.5%) stated 
Table 3. Survey results, current practice (G1: Group 1; G2: Group 2; G3: Group 3). (cont.)
   n %
Q17. What is your practice if there is need to exceed safe tourniquet inflation time
during surgery?
 Proceed with the surgery without tourniquet 48 (G1: 22; G2: 19; G3: 7) 49.0
 Deflate the tourniquet, reuse after 5 min break 12 (G1: 2; G2: 8; G3: 2) 12.2
 Deflate the tourniquet, reuse after 15 min break 24 (G1: 14; G2: 2; G3: 8) 24.5
 Deflate the tourniquet, reuse after 30 min break 11 (G1: 3; G2: 7; G3: 1) 11.2
 Other 3 (G1: 1; G2: 0; G3: 2) 3.1
Q18. Which is/are contraindication(s) of tourniquet application for extremity surgeries?
 Peripheral vascular disease 13 (G1: 6; G2: 7; G3: 0) 13.4
 Infection 3 (G1: 0; G2: 1; G3: 2) 3.1
 Malignancy 3 (G1: 2; G2: 1; G3: 0) 3.1
 Sickle cell anemia history 2 (G1: 1; G2: 1; G3: 0) 2.1
 All of the above 76 (G1: 33; G2: 26; G3: 17) 78.4
 (One participant did not answer the question)
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that they use a plain cuff. However, reports in the lit-
erature detail the importance of contoured cuffs and 
how it may be impossible to obtain proper fit of the 
plain cuff on extremities of obese patients with limb 
tapering. Moreover, it is possible to use lower inflation 
pressures with contoured cuffs.[6–9] To be noted, use of a 
plain cuff is acceptable in appropriate cases. Wide cuffs 
have a more gradual pressure profile at all tissue depths, 
with peak pressures at the midposition of its width and 
lowest pressures at the periphery of the cuff.[10,11] Fur-
thermore, wide cuffs require lower inflation pressures to 
stop the flow of arterial blood distal to the cuff.[6] There 
is an inverse relationship between limb occlusion pres-
sure and the ratio of cuff width to limb circumference.[7] 
The width should be the widest possible but should not 
encroach upon the surgical site.[12] However, some stud-
ies have reported that narrower cuffs might result in less 
nerve damage during short term application.[13,14] Cuff 
length is important; it should be individualized accord-
ing to the circumference of the patient’s limb and should 
overlap at least 3 inches but not more than 6 inches to 
cause generation of high pressure.[15,16]
Institutional habits often determine which member 
of staff (personnel, nurse, surgeon, assistant) is respon-
sible for tourniquet application.[17] Assistant (44.3%) 
and orthopedic theatre personnel (34%) were reported 
predominantly as responsible for tourniquet application. 
However, the surgeon is the person who is ultimately 
responsible for any consequences that may arise from 
tourniquet use.[15,18]
Tourniquet-related complications can be clinically 
devastating to the patient and may have significant 
medicolegal implications.[3,19,20] Most surgical trainees 
do not undergo formal training on tourniquet use; thus, 
most surgeons do not receive any education on proper 
tourniquet use either. However, it is advised that com-
pulsory formal education regarding proper tourniquet 
use be given to all personnel every 6 months.[17] Consis-
tent with the literature, 69.1% of participants had not 
received formal education about tourniquet use, and few 
participants (<4.1%) stated that they had received infor-
mal one-to-one training on tourniquet use. 
Systemic complications are related to tourniquet 
inflation and deflation; however, local complications re-
sult from the direct effect of cuff compression and tis-
sue hypoperfusion.[6,21] The most commonly reported 
complications are skin blistering, and muscle and nerve 
injury.[6,21] The combined effect of mechanical compres-
sion beneath the tourniquet and prolonged duration of 
ischemia is responsible for neuromuscular complications.
[6,22] Soaking the cast padding with skin preparation solu-
tions may cause chemical burns under the tourniquets.
[15,23,24] Approximately 25% of participants reported that 
they have encountered one or more complications. Nota-
bly, more than 50% of academic staff reported complica-
tion experience, although this ratio was low in the other 
groups. The results suggest that orthopedic surgeons and 
residents may have a bias regarding this issue. Although 
orthopedic surgeons are aware of complications related 
to tourniquet usage, these problems may be neglected or 
escape observation due to intense working conditions.
Of participants, 78.6% reported that details of tour-
niquet use were recorded regularly. However, the rate of 
unrecorded details (21.4%) seems unacceptable. Appro-
priate records may be helpful in solving problems with 
potential medicolegal implications. Padding decreases 
shear stresses at the skin surface, and thus can prevent 
skin injuries.[25,26] Caution should be taken when us-
ing excessive padding, as it may reduce the efficiency of 
the tourniquet by increasing the limb circumference.[27] 
Most participants (94.9%) in the present study main-
tained padding recommendations as described in the 
literature. The tourniquet cuff should be applied in a lo-
cation with adequate muscle mass, usually proximally, to 
protect nerves and vessels.[12,15] Responses in the survey 
about cuff placement localization were consistent with 
the literature (80.6% most proximally, 16.3% region of 
most muscle mass). Half of the participants in Group 3 
reported that they applied the cuff in the region with the 
most muscle mass on the extremity (F=5.530, p=0.005).
There is no consensus on determination of optimum 
tourniquet pressure in extremities. The target is the 
lowest pressure that provides adequate tissue identifica-
tion and visualization. There are many pressure setting 
methods used in clinical practice: fixed inflation pressure 
(typically 200–250 mmHg for upper arm and 300–
350 mmHg for thigh), limb occlusion pressure (LOP) 
determination, arterial occlusion pressure estimation 
(AOPE), and fixed set pressure above systolic arterial 
pressure (systolic blood pressure plus 100 mmHg for 
upper arm and 100–150 mmHg for thigh).[12,21,28–30] We 
believe that determining the tourniquet pressure method 
should have a scientific basis and be simple, consistent, 
and expeditious. Scientifically valid options at lowest 
inflation pressure are LOP determination and AOPE 
methods.[6,12,21,30] These were not observed among the 
results at the expected rates, with academic staff even 
reporting 0% use. Traditional recommendations sug-
gest parameters for maximum pressure rather than 
minimal effective pressure to achieve a bloodless field.
[29] Controlled hypotension with decreased cuff inflation 
pressure is considerably important.[12,31] For LOP deter-
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mination, a margin of error of 50–100 mmHg is added 
in consideration of dynamic conditions during surgery.
[6,12,21] In children, a standard safety margin of 50 mmHg 
is recommended for all LOP determinations.[6,12,32,33]
Advantages of exsanguination of the extremity are es-
tablishing a clear operating field and reducing blood loss. 
Most survey participants (approximately 90%) preferred 
exsanguination of the extremity before tourniquet appli-
cation, but there was no dominant exsanguination meth-
od chosen by the participants. The 3 main exsanguination 
methods were elevation, squeeze method, and Esmarch 
bandage. The most effective method is Esmarch bandage; 
however, both squeeze method and Esmarch bandage 
equally create a clear surgical field.[34,35] Simple elevation 
can achieve a good result where mechanical limb exsan-
guination is contraindicated,[6] with 5 minutes elevation 
appropriate for adequate exsanguination of limbs.[6,12]
Optimal time interval between antibiotic administra-
tion and tourniquet inflation is important for antibiotic 
prophylaxis, as efficiency of the prophylactic antibiotics 
requires tissue perfusion of the surgical site.[15,16] Antibi-
otic administration 5 minutes prior to tourniquet infla-
tion has been reported as adequate to allow sufficient tis-
sue perfusion, although antibiotics reach optimum tissue 
concentrations when they are administered 20 minutes 
prior to tourniquet inflation.[36–39] A 20–30 minute in-
terval between antibiotic administration and tourniquet 
inflation was the most frequently chosen interval by sur-
vey participants (n=68, 69.4%).
There is no defined safe time period of tourniquet 
inflation for both upper and lower extremities.[6,21] De-
spite the wide interval of recommended times for both, 
the most commonly cited value is 120 minutes.[12,21] All 
attempts should be made to decrease tourniquet infla-
tion time. Most survey participants stated they used 
120 minutes inflation time for lower and 90 minutes 
for upper extremities (n=44, 44.9%). These values are 
consistent with the literature. There are few reports ad-
dressing proper tourniquet use in pediatrics, and less 
than 75 minutes of cuff inflation time for lower extremi-
ties in pediatric patients has been recommended.[32,40] 
However, only 38 participants’ (39.2%) responses were 
consistent with the literature, according to tourniquet 
inflation time for pediatric patients with inflation time 
≤75 minutes.
If tourniquet inflation time remains below 2 hours, 
after inflation of the cuff, histological, electrophysiologi-
cal, and functional impacts of the tourniquet remain 
reversible.[13] It is possible to use the deflation and rein-
flation method after a set period.[12,16,21] In the method, 
readjustment of the interval is related directly to tourni-
quet time, and it is assumed that a 15–20 minute inter-
val is acceptable for 120 minutes tourniquet time (the 
tourniquet should be deflated for 5 minutes for every 
30 minutes of inflation time).[12,16,21] Proceeding with 
the surgery without tourniquet is a challenging option 
and was chosen by 48 participants (49%). Fifteen and 
30 minute breaks between deflation and inflation of the 
tourniquet is consistent with the literature but were cho-
sen by only 35 participants (35.7%).
If the surgeon encounters intraoperative bleeding 
with an inflated extremity tourniquet, he or she should 
consider underpressurized cuff, insufficient exsanguina-
tion (leakage), improper cuff selection, loosely applied 
cuff, and calcified vessels as possible causes.[12,31] Intra-
operatively increased blood pressure should also be 
evaluated. Responses showed that approximately 50% 
of participants do not have sufficient clinical knowledge 
to overcome this worst-case scenario. 
Seventy-six participants (78.4%) agreed with the 
literature regarding contraindications/relative contra-
indications. Use of Esmarch bandage is relatively con-
traindicated when treating either an infection or tumor.
[21] Other contraindications are infection, open fracture, 
tumor distal to tourniquet, sickle cell anemia, previous 
revascularization of extremity, extremity with dialysis 
access, and venous thromboembolism.[6,12,15] In patients 
with arterial calcification, higher pressures are needed to 
obtain blood flow occlusion.[6]
Yalçınkaya et al.[5] recently reported a descriptive sur-
vey focused on pneumatic tourniquet utilization among 
orthopedic surgeons and residents in Istanbul, Turkey. 
However, the study has limitations that include lack of 
information about cuff type, education on tourniquet 
utilization, recording of details related to pneumatic 
tourniquet, cuff localization on extremity, arterial occlu-
sion pressure estimation method to produce the lowest 
cuff pressure, relationship between antibiotic prophylax-
is and tourniquet utilization, and worst-case scenarios 
(utilization of tourniquet for more than 2 hours and 
intraoperative bleeding despite tourniquet utilization). 
They investigated 2 groups consisting of orthopedic sur-
geons and residents; however, we investigated 3 groups: 
orthopedic surgeons, residents, and academic staff. The 
purpose of this demographic selection was to evaluate 
tourniquet utilization habits of academic staff and com-
pare them with those of the other participants; this re-
lationship is significant because the academic staff are in 
the position of educating others regarding proper tour-
niquet use.
Limitations of our study include the lack of infor-
mation about systemic harmful effects of tourniquet 
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use, limited number of participants evaluated, lack of 
classification of intraoperative/postoperative and local/
systemic complications, and lack of information on the 
orthopedic experience level of participants.
In conclusion, the results indicate that there is a wide 
variation in some aspects of tourniquet practice by par-
ticipants in this pilot study. Although results were not 
totally inconsistent with the literature, the discrepan-
cies found are not acceptable because of the significant 
complications that may result. This is a small sample 
group, but we believe it is representative of the greater 
orthopedic surgeon population in Turkey. Additionally, 
the Turkish Society of Orthopedics and Traumatology 
must further evaluate the level of knowledge regarding 
tourniquet use of orthopedic surgeons in Turkey with a 
larger survey. In our opinion, there is a need to provide 
and ensure adequate education to provide the best pa-
tient care, and protocols should be developed for accept-
able practice standards of tourniquet use.
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